Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort SMART vs Standard Therapy for Asthma Relapse Prevention (PARADE)
NCT00326053Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- May 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of budesonide + formoterol in asthma, sponsored by AstraZeneca. Started May 2006; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00326053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00326053.